SCHEDULED SYSTEM MAINTENANCE – Monday 6 October to Tuesday 7 October 2025. We expect no disruption to services. For further assistance please contact the Library team, library@massey.ac.nz
Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register using a personal email and password.Have you forgotten your password?
Repository logo
    Info Pages
    Content PolicyCopyright & Access InfoDepositing to MRODeposit LicenseDeposit License SummaryFile FormatsTheses FAQDoctoral Thesis Deposit
  • Communities & Collections
  • All of MRO
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register using a personal email and password.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Vangala G"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    The dose-dependent effect of acute ozone exposure on lung function and the efficacy of a Boysenberry apple powder blend (BerriQi®) in reducing throat irritation and symptom recovery time in healthy adults
    (Elsevier B V, 2025-09-01) Lomiwes D; Barnes M; Nicholls G; Ngametua N; Sawyer G; Kanon AP; Vangala G; Shaw O
    Urbanization and industrialization have impacted air quality and health, with ozone exposure linked to reduced lung function and increased respiratory issues. This study characterised the dose-dependent effect of acute, controlled ambient ozone exposure in an environmental chamber on lung function, then investigated the effect of BerriQi® Boysenberry and apple powder (BerriQi) ozone-induced respiratory irritation symptoms. In an incremental dose study, healthy adults were exposed to 0.1, 0.2 or 0.3 ppm ozone for 2 h. Forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) were measured at designated timepoints up to 48 h after ozone exposure. This was followed by a randomised, double-blind, placebo-controlled crossover trial, with healthy adults (n = 20) who consumed either BerriQi or a placebo daily for 5 days before being exposed to 0.2 ppm ozone for 2 h. Respiratory irritation symptoms, including throat irritation (TI), soreness of cough (SOC), shortness of breath (SOB), and pain on deep inspiration (PODI), were assessed at designated timepoints up to 48 h after ozone exposure. Our results showed that 0.2 ppm ozone was the maximum tolerated dose that elicited a temporal decline in lung function in healthy participants and that BerriQi supplementation significantly reduced TI (p = 0.04), and may expedite the resolution of SOC, SOB and PODI after acute ozone exposure. These findings suggest that BerriQi may alleviate the severity and duration of ozone-induced respiratory irritation and highlights the potential of BerriQi as a dietary intervention for mitigating the respiratory effects of air pollution.

Copyright © Massey University  |  DSpace software copyright © 2002-2025 LYRASIS

  • Contact Us
  • Copyright Take Down Request
  • Massey University Privacy Statement
  • Cookie settings